Effect of PRP, PPP, & BMAC on Functional Outcomes Following Hip Arthroscopy for Acetabular Labral Pathologies

Launched by MASSACHUSETTS GENERAL HOSPITAL · Aug 18, 2023

Keywords

ClinConnect Summary

This clinical trial is investigating how different treatments—specifically, Platelet-Rich Plasma (PRP), Platelet-Poor Plasma (PPP), and Bone Marrow Aspirate Concentrate (BMAC)—can help improve recovery after hip surgery for issues related to the acetabular labrum, which is a cartilage structure in the hip joint. The main goals are to see if these treatments can enhance the overall function of the hip after surgery and if they can help reduce the risk of arthritis in patients with labral problems.

To participate in this trial, you need to be at least 18 years old and have a medical recommendation for hip surgery to treat a labral issue. You should also be willing to be randomly assigned to receive one of the treatments being studied. It’s important to note that if you have had previous surgeries on the same hip or do not speak English, you may not be eligible for this study. If you decide to join, you can expect to help researchers learn more about these treatments and their potential benefits for hip surgery recovery.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age: \> or equal to 18 years
• • Clinically indicated for hip arthroscopy (by the study PI) to address a labral pathology
• • Willingness to participate, amenable to randomization into either treatment arm of the research study, and the ability to understand \& sign the informed consent document
• Exclusion Criteria:
• • Non-English speaking (PROM surveys are only validated in English)
• • Prior same site (i.e., ipsilateral hip) surgery, including but not limited to previous hip arthroscopy, core decompression, or periacetabular osteotomies